Quarterly Results

CHOKSI LABORATORIES LTD.

NSE : NABSE : 526546ISIN CODE : INE493D01013Industry : Hospital & Healthcare ServicesHouse : Private
BSE197.003.3 (+1.7 %)
PREV CLOSE ( ) 193.70
OPEN PRICE ( ) 194.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4083
TODAY'S LOW / HIGH ( )191.00 197.00
52 WK LOW / HIGH ( ) 56.16197.95
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
114.44
103.84
92.62
107.41
Total Expenditure
78.99
78.41
69.04
79.04
PBIDT (Excl OI)
35.45
25.43
23.58
28.37
Other Income
NA
0.08
0.09
NA
Operating Profit
35.45
25.52
23.67
28.38
Interest
5.82
6.92
6.57
7.19
Exceptional Items
NA
NA
NA
NA
PBDT
29.63
18.6
17.1
21.19
Depreciation
17.04
16.78
16.13
15.04
Profit Before Tax
12.59
1.82
0.97
6.15
Tax
3.38
0.77
0.21
1.94
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
9.21
1.05
0.76
4.21
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
9.21
1.05
0.76
4.21
Equity Capital
69.65
69.65
69.65
69.65
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
1.32
0.15
0.10
0.60
Calculated EPS (Annualised)
5.28
0.60
0.43
2.41
No of Public Share Holdings
4772509
4772509
4772509
4772509
% of Public Share Holdings
68.52
68.52
68.52
68.52
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
30.97
24.48
25.45
26.41
PBIDTM%
30.97
24.57
25.55
26.42
PBDTM%
25.89
17.91
18.46
19.72
PBTM%
11.00
1.75
1.04
5.72
PATM%
8.04
1.01
0.82
3.91
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.